TY - JOUR
T1 - Xylose donor transport is critical for fungal virulence
AU - Li, Lucy X.
AU - Rautengarten, Carsten
AU - Heazlewood, Joshua L.
AU - Doering, Tamara L.
N1 - Funding Information:
This work was funded by National Institutes of Health grants R21 AI109623, R01 GM066303, and R01 AI087794 to TLD, and a Mizutani Foundation for Glycoscience grant to JLH and CR (160151). LXL was partly supported by a National Research Science Award (T32 GM007200), a Sondra Schlesinger Graduate Fellowship (Washington University St. Louis Microbiology Department), and a National Institute of Allergy and Infectious Diseases award (F30AI120339). JLH was supported by an ARC Future Fellowship (FT130101165). Substrates from Carbosource Services (Athens, GA) were supported in part by a NSF-RCN grant (0090281). Glycan compositional and linkage analyses at the Complex Carbohydrate Research Center (Athens, GA) were supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy grants DE-FG02-93ER20097 and DE-FG02-96ER20220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the members of the Doering laboratory for insightful discussions and assistance with experiments (Cara Griffith for initial gene identification; Dr. Zeke Maier and Dr. Stacey Gish for transcriptional analysis; Matthew Williams for mouse studies; and Dr. Camaron Hole for macrophage experiments). We also thank Dr. Wandy Beatty (Washington University School of Medicine) for TEM, Dr. Jeff Brodsky (University of Pittsburgh) for αKar2p/BiP antibody, Dr. Benjamin S. Glick (University of Chicago) for the Sec7-3xGFP S. cerevisiae strain, Dr. Joe Heitman (Duke University) for C. neoformans KN99α, Dr. Thomas R. Kozel (University of Nevada School of Medicine) for anti-GXM mAbs, and Dr. Jennifer Lodge (Washington University School of Medicine) for plasmid pMH12-T.
Publisher Copyright:
© 2018 Li et al.
PY - 2018/1
Y1 - 2018/1
N2 - Cryptococcus neoformans, an AIDS-defining opportunistic pathogen, is the leading cause of fungal meningitis worldwide and is responsible for hundreds of thousands of deaths annually. Cryptococcal glycans are required for fungal survival in the host and for pathogenesis. Most glycans are made in the secretory pathway, although the activated precursors for their synthesis, nucleotide sugars, are made primarily in the cytosol. Nucleotide sugar transporters are membrane proteins that solve this topological problem, by exchanging nucleotide sugars for the corresponding nucleoside phosphates. The major virulence factor of C. neoformans is an anti-phagocytic polysaccharide capsule that is displayed on the cell surface; capsule polysaccharides are also shed from the cell and impede the host immune response. Xylose, a neutral monosaccharide that is absent from model yeast, is a significant capsule component. Here we show that Uxt1 and Uxt2 are both transporters specific for the xylose donor, UDP-xylose, although they exhibit distinct subcellular localization, expression patterns, and kinetic parameters. Both proteins also transport the galactofuranose donor, UDP-galactofuranose. We further show that Uxt1 and Uxt2 are required for xylose incorporation into capsule and protein; they are also necessary for C. neoformans to cause disease in mice, although surprisingly not for fungal viability in the context of infection. These findings provide a starting point for deciphering the substrate specificity of an important class of transporters, elucidate a synthetic pathway that may be productively targeted for therapy, and contribute to our understanding of fundamental glycobiology.
AB - Cryptococcus neoformans, an AIDS-defining opportunistic pathogen, is the leading cause of fungal meningitis worldwide and is responsible for hundreds of thousands of deaths annually. Cryptococcal glycans are required for fungal survival in the host and for pathogenesis. Most glycans are made in the secretory pathway, although the activated precursors for their synthesis, nucleotide sugars, are made primarily in the cytosol. Nucleotide sugar transporters are membrane proteins that solve this topological problem, by exchanging nucleotide sugars for the corresponding nucleoside phosphates. The major virulence factor of C. neoformans is an anti-phagocytic polysaccharide capsule that is displayed on the cell surface; capsule polysaccharides are also shed from the cell and impede the host immune response. Xylose, a neutral monosaccharide that is absent from model yeast, is a significant capsule component. Here we show that Uxt1 and Uxt2 are both transporters specific for the xylose donor, UDP-xylose, although they exhibit distinct subcellular localization, expression patterns, and kinetic parameters. Both proteins also transport the galactofuranose donor, UDP-galactofuranose. We further show that Uxt1 and Uxt2 are required for xylose incorporation into capsule and protein; they are also necessary for C. neoformans to cause disease in mice, although surprisingly not for fungal viability in the context of infection. These findings provide a starting point for deciphering the substrate specificity of an important class of transporters, elucidate a synthetic pathway that may be productively targeted for therapy, and contribute to our understanding of fundamental glycobiology.
UR - http://www.scopus.com/inward/record.url?scp=85041515522&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1006765
DO - 10.1371/journal.ppat.1006765
M3 - Article
C2 - 29346417
AN - SCOPUS:85041515522
VL - 14
JO - PLoS Pathogens
JF - PLoS Pathogens
SN - 1553-7366
IS - 1
M1 - e1006765
ER -